New Research Reveals the Decline in Cardiovascular Disease Deaths in RA Sufferers

Photo of author

(Newswire.net — April 3, 2017) Orlando, FL — There is no question that rheumatoid arthritis is a painful and debilitating condition. Unfortunately, RA has also been linked with the development of various diseases and disorders, including those that affect the heart.

New research reveals the decline in cardiovascular disease deaths in RA sufferers. This decline was discovered when a comparison was made involving individuals diagnosed with rheumatoid arthritis in the previous decades and those without the disease. The research study was presented at the American College of Rheumatology Annual Meeting in San Francisco.

The condition is the most common chronic autoimmune disease affecting the joints. It has the potential to cause joint damage and deformity accompanied with loss of function. It has not been established yet what exactly causes RA. However, it has been found to impact individuals of all ages and particularly women.

Some of the symptoms of the condition are swelling, pain, and stiffness in multiple joints. It can actually impact many joints, but it is usually the small joints in the feet and hands that are involved.

Rheumatoid arthritis has been linked with increased risk of cardiovascular disease and cardiovascular death versus those without the condition.

According to Elena Myasoedova, MD, PhD; Assistant Professor of Medicine, Department of Internal Medicine, Mayo Clinic and lead investigator of the study, in the previous decades there hasn’t been a decline in the increased cardiovascular risk.

She also added that only very few research studies looked into the risk of cardiovascular death in individuals who have recently been diagnosed with rheumatoid arthritis. It has actually remained unclear whether it is due to early effective treatments or the changes in the era of enhanced diagnostics.

In the study, the research team assessed the cardiovascular disease death trends in 315 individuals who suffered from rheumatoid arthritis between 2000 and 2007. The findings were compared to the trends among 498 individuals who suffered from the condition earlier as well as to 813 participants without the condition.

There are several factors believed to contribute to cardiovascular problems in individuals with rheumatoid arthritis, and one is the use of certain pharmaceutical drugs such as pain medications. Pain medications have long been linked with side effects, and this is why more and more sufferers are turning to natural alternatives.

One of these natural alternatives is glucosamine, which is thought to be one of the most popular joint enhancement supplements today. Glucosamine is popular not just among arthritis sufferers, but also athletes.

Today, there are many glucosamine products available in the market. Some of the most popular of which contain other potentially therapeutic ingredients, such as chondroitin, methylsulfonylmethane, and turmeric.
(www.amazon.com/condroitina-glucosamina-msm/dp/B00DUMO9X4)

About VitaBreeze

VitaBreeze is a nutraceutical brand that manufactures high-quality natural supplements to help people live a healthy, enjoyable, and longer life. All of the company’s products are manufactured in the United States using the finest-quality ingredients that have been carefully selected, tested, and crafted into the firm’s winning formulas. Visit http://www.VitaBreeze.com to learn more.

VitaBreeze

4700 Millenia Blvd
Suite 175 F
Orlando, FL 32839
United States
(407) 545-2239
media@vitabreeze.com
http://www.VitaBreeze.com